Predictive markers for delayed lymph node metastases and survival in early‐stage oral squamous cell carcinoma

ABSTRACT Background The purpose of this study was to identify clinicopathological and immunohistochemical factors predicting delayed lymph node metastases and survival in early oral squamous cell carcinoma (OSCC). Methods The study included 85 consecutive patients with clinically T1 to T2N0 OSCC who...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2017-04, Vol.39 (4), p.694-701
Hauptverfasser: Luksic, Ivica, Suton, Petar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 701
container_issue 4
container_start_page 694
container_title Head & neck
container_volume 39
creator Luksic, Ivica
Suton, Petar
description ABSTRACT Background The purpose of this study was to identify clinicopathological and immunohistochemical factors predicting delayed lymph node metastases and survival in early oral squamous cell carcinoma (OSCC). Methods The study included 85 consecutive patients with clinically T1 to T2N0 OSCC who were primarily surgically treated between 2000 and 2004. Results There were 68 men and 17 women (median age, 61 years; range, 34–82 years). Of all the patients, 25 (29.4%) developed delayed lymph node metastases within 3 to 42 months after treatment of the primary tumor. Multivariate logistic regression analysis identified poorly differentiated tumors, low laminin, and high fibronectin expression as prognosticators of delayed lymph node metastases. Cox's proportional hazards regression analysis demonstrated that moderately differentiated tumors and delayed lymph node metastases had predictive value regarding survival. Conclusion Large prospective investigations with reproducibility and the clinical translatability of immunohistochemical methods are needed in order to provide new and effective therapeutic strategies in the future. © 2016 Wiley Periodicals, Inc. Head Neck 39: 694–701, 2017
doi_str_mv 10.1002/hed.24667
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1881758776</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1881758776</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2427-b1485e22a4c401fd76016258fad1d02b66fb1e840689207f87393dcc4fd0c3743</originalsourceid><addsrcrecordid>eNqNkclOxDAMhiMEYhk48AIoEhcuZZylSXpE7BISHOBcZRqXKXSZSaaDeuMReEaehAzbgROSJVv-P1m2f0L2GRwzAD6eojvmUim9RrYZZDoBIfX6qpYiEaDlFtkJ4QkAhJJ8k2xxA6DAyG3S3Xl0VbGolkgb65_RB1p2njqs7YCO1kMzm9K2c1HGhQ0xMFDbOhp6v6yWtqZVS9H6enh_fYvyI9LOx26Y97bp-kALrGtaWF9UbdfYXbJR2jrg3ncekYeL8_vTq-Tm9vL69OQmmXHJdTJh0qTIuZWFBFY6rYApnprSOuaAT5QqJwyNBGUyDro0WmTCFYUsHRRCSzEiR19zZ76b9xgWeVOF1Sq2xbhVzoxhOjVaq3-gKdeGpwwievgHfep638ZDIqXTTINSWaQOvql-0qDLZ76Krx3yn69HYPwFvFQ1Dr86g3xlZx7tzD_tzK_Ozz4L8QG8tpIy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875970669</pqid></control><display><type>article</type><title>Predictive markers for delayed lymph node metastases and survival in early‐stage oral squamous cell carcinoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Luksic, Ivica ; Suton, Petar</creator><creatorcontrib>Luksic, Ivica ; Suton, Petar</creatorcontrib><description>ABSTRACT Background The purpose of this study was to identify clinicopathological and immunohistochemical factors predicting delayed lymph node metastases and survival in early oral squamous cell carcinoma (OSCC). Methods The study included 85 consecutive patients with clinically T1 to T2N0 OSCC who were primarily surgically treated between 2000 and 2004. Results There were 68 men and 17 women (median age, 61 years; range, 34–82 years). Of all the patients, 25 (29.4%) developed delayed lymph node metastases within 3 to 42 months after treatment of the primary tumor. Multivariate logistic regression analysis identified poorly differentiated tumors, low laminin, and high fibronectin expression as prognosticators of delayed lymph node metastases. Cox's proportional hazards regression analysis demonstrated that moderately differentiated tumors and delayed lymph node metastases had predictive value regarding survival. Conclusion Large prospective investigations with reproducibility and the clinical translatability of immunohistochemical methods are needed in order to provide new and effective therapeutic strategies in the future. © 2016 Wiley Periodicals, Inc. Head Neck 39: 694–701, 2017</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.24667</identifier><identifier>PMID: 28006084</identifier><identifier>CODEN: HEANEE</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor - analysis ; Biopsy, Needle ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - therapy ; Cohort Studies ; delayed lymph node metastases ; Disease-Free Survival ; Female ; Fibronectins - analysis ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Laminin - analysis ; Lymph Nodes - pathology ; Lymphatic Metastasis - pathology ; Male ; Middle Aged ; Mouth Neoplasms - mortality ; Mouth Neoplasms - pathology ; Mouth Neoplasms - therapy ; Neoplasm Invasiveness - pathology ; Neoplasm Staging ; oral cancer ; Predictive Value of Tests ; Prognosis ; prognostic factors ; Proportional Hazards Models ; recurrence ; Retrospective Studies ; survival ; Survival Analysis</subject><ispartof>Head &amp; neck, 2017-04, Vol.39 (4), p.694-701</ispartof><rights>2016 Wiley Periodicals, Inc.</rights><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-9138-2037</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhed.24667$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhed.24667$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28006084$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luksic, Ivica</creatorcontrib><creatorcontrib>Suton, Petar</creatorcontrib><title>Predictive markers for delayed lymph node metastases and survival in early‐stage oral squamous cell carcinoma</title><title>Head &amp; neck</title><addtitle>Head Neck</addtitle><description>ABSTRACT Background The purpose of this study was to identify clinicopathological and immunohistochemical factors predicting delayed lymph node metastases and survival in early oral squamous cell carcinoma (OSCC). Methods The study included 85 consecutive patients with clinically T1 to T2N0 OSCC who were primarily surgically treated between 2000 and 2004. Results There were 68 men and 17 women (median age, 61 years; range, 34–82 years). Of all the patients, 25 (29.4%) developed delayed lymph node metastases within 3 to 42 months after treatment of the primary tumor. Multivariate logistic regression analysis identified poorly differentiated tumors, low laminin, and high fibronectin expression as prognosticators of delayed lymph node metastases. Cox's proportional hazards regression analysis demonstrated that moderately differentiated tumors and delayed lymph node metastases had predictive value regarding survival. Conclusion Large prospective investigations with reproducibility and the clinical translatability of immunohistochemical methods are needed in order to provide new and effective therapeutic strategies in the future. © 2016 Wiley Periodicals, Inc. Head Neck 39: 694–701, 2017</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Biopsy, Needle</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Cohort Studies</subject><subject>delayed lymph node metastases</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Fibronectins - analysis</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kaplan-Meier Estimate</subject><subject>Laminin - analysis</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Neoplasms - mortality</subject><subject>Mouth Neoplasms - pathology</subject><subject>Mouth Neoplasms - therapy</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Neoplasm Staging</subject><subject>oral cancer</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>prognostic factors</subject><subject>Proportional Hazards Models</subject><subject>recurrence</subject><subject>Retrospective Studies</subject><subject>survival</subject><subject>Survival Analysis</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkclOxDAMhiMEYhk48AIoEhcuZZylSXpE7BISHOBcZRqXKXSZSaaDeuMReEaehAzbgROSJVv-P1m2f0L2GRwzAD6eojvmUim9RrYZZDoBIfX6qpYiEaDlFtkJ4QkAhJJ8k2xxA6DAyG3S3Xl0VbGolkgb65_RB1p2njqs7YCO1kMzm9K2c1HGhQ0xMFDbOhp6v6yWtqZVS9H6enh_fYvyI9LOx26Y97bp-kALrGtaWF9UbdfYXbJR2jrg3ncekYeL8_vTq-Tm9vL69OQmmXHJdTJh0qTIuZWFBFY6rYApnprSOuaAT5QqJwyNBGUyDro0WmTCFYUsHRRCSzEiR19zZ76b9xgWeVOF1Sq2xbhVzoxhOjVaq3-gKdeGpwwievgHfep638ZDIqXTTINSWaQOvql-0qDLZ76Krx3yn69HYPwFvFQ1Dr86g3xlZx7tzD_tzK_Ozz4L8QG8tpIy</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>Luksic, Ivica</creator><creator>Suton, Petar</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9138-2037</orcidid></search><sort><creationdate>201704</creationdate><title>Predictive markers for delayed lymph node metastases and survival in early‐stage oral squamous cell carcinoma</title><author>Luksic, Ivica ; Suton, Petar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2427-b1485e22a4c401fd76016258fad1d02b66fb1e840689207f87393dcc4fd0c3743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Biopsy, Needle</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Cohort Studies</topic><topic>delayed lymph node metastases</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Fibronectins - analysis</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kaplan-Meier Estimate</topic><topic>Laminin - analysis</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Neoplasms - mortality</topic><topic>Mouth Neoplasms - pathology</topic><topic>Mouth Neoplasms - therapy</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Neoplasm Staging</topic><topic>oral cancer</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>prognostic factors</topic><topic>Proportional Hazards Models</topic><topic>recurrence</topic><topic>Retrospective Studies</topic><topic>survival</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luksic, Ivica</creatorcontrib><creatorcontrib>Suton, Petar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Head &amp; neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luksic, Ivica</au><au>Suton, Petar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive markers for delayed lymph node metastases and survival in early‐stage oral squamous cell carcinoma</atitle><jtitle>Head &amp; neck</jtitle><addtitle>Head Neck</addtitle><date>2017-04</date><risdate>2017</risdate><volume>39</volume><issue>4</issue><spage>694</spage><epage>701</epage><pages>694-701</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><coden>HEANEE</coden><abstract>ABSTRACT Background The purpose of this study was to identify clinicopathological and immunohistochemical factors predicting delayed lymph node metastases and survival in early oral squamous cell carcinoma (OSCC). Methods The study included 85 consecutive patients with clinically T1 to T2N0 OSCC who were primarily surgically treated between 2000 and 2004. Results There were 68 men and 17 women (median age, 61 years; range, 34–82 years). Of all the patients, 25 (29.4%) developed delayed lymph node metastases within 3 to 42 months after treatment of the primary tumor. Multivariate logistic regression analysis identified poorly differentiated tumors, low laminin, and high fibronectin expression as prognosticators of delayed lymph node metastases. Cox's proportional hazards regression analysis demonstrated that moderately differentiated tumors and delayed lymph node metastases had predictive value regarding survival. Conclusion Large prospective investigations with reproducibility and the clinical translatability of immunohistochemical methods are needed in order to provide new and effective therapeutic strategies in the future. © 2016 Wiley Periodicals, Inc. Head Neck 39: 694–701, 2017</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28006084</pmid><doi>10.1002/hed.24667</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9138-2037</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1043-3074
ispartof Head & neck, 2017-04, Vol.39 (4), p.694-701
issn 1043-3074
1097-0347
language eng
recordid cdi_proquest_miscellaneous_1881758776
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Aged, 80 and over
Biomarkers, Tumor - analysis
Biopsy, Needle
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - therapy
Cohort Studies
delayed lymph node metastases
Disease-Free Survival
Female
Fibronectins - analysis
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Laminin - analysis
Lymph Nodes - pathology
Lymphatic Metastasis - pathology
Male
Middle Aged
Mouth Neoplasms - mortality
Mouth Neoplasms - pathology
Mouth Neoplasms - therapy
Neoplasm Invasiveness - pathology
Neoplasm Staging
oral cancer
Predictive Value of Tests
Prognosis
prognostic factors
Proportional Hazards Models
recurrence
Retrospective Studies
survival
Survival Analysis
title Predictive markers for delayed lymph node metastases and survival in early‐stage oral squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T01%3A01%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20markers%20for%20delayed%20lymph%20node%20metastases%20and%20survival%20in%20early%E2%80%90stage%20oral%20squamous%20cell%20carcinoma&rft.jtitle=Head%20&%20neck&rft.au=Luksic,%20Ivica&rft.date=2017-04&rft.volume=39&rft.issue=4&rft.spage=694&rft.epage=701&rft.pages=694-701&rft.issn=1043-3074&rft.eissn=1097-0347&rft.coden=HEANEE&rft_id=info:doi/10.1002/hed.24667&rft_dat=%3Cproquest_pubme%3E1881758776%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1875970669&rft_id=info:pmid/28006084&rfr_iscdi=true